Monopar Therapeutics Inc. buy BiotechBee
Start price
08.06.24
/
50%
€0.71
Target price
31.01.26
€1.00
Performance (%)
-37.59%
End price
14.12.24
-
Summary
This prediction is currently being closed. The BUY prediction by BiotechBee for Monopar Therapeutics Inc. is performing very badly with a performance of -37.59%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
According to BiotechBee what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year